Recognizing the Role of the Reticuloendothelial System in the Late Phase of US Contrast Agents.
作者信息
Khalili Korosh, Atri Mostafa, Kim Tae Kyoung, Jang Hyun-Jung
机构信息
From the Department of Medical Imaging, University of Toronto, 610 University Ave, Room 3-964, Toronto, ON, Canada M5G 2M9; and Joint Department of Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, Toronto, Canada.
出版信息
Radiology. 2021 Feb;298(2):287-291. doi: 10.1148/radiol.2020203245. Epub 2020 Dec 8.
PMID:33290174
Abstract
摘要
相似文献
1
Recognizing the Role of the Reticuloendothelial System in the Late Phase of US Contrast Agents.认识网状内皮系统在美国造影剂晚期阶段的作用。
Radiology. 2021 Feb;298(2):287-291. doi: 10.1148/radiol.2020203245. Epub 2020 Dec 8.
2
[Ultrasound contrast imaging with next generation contrast agents].
Nihon Rinsho. 2001 Oct;59 Suppl 6:314-7.
3
Tumor Contrast Imaging with Gas Vesicles by Circumventing the Reticuloendothelial System.气体囊泡绕过网状内皮系统的肿瘤对比成像。
Ultrasound Med Biol. 2020 Feb;46(2):359-368. doi: 10.1016/j.ultrasmedbio.2019.09.009. Epub 2019 Nov 8.
4
New RES-specific contrast agents for CT.
Acad Radiol. 2002 May;9 Suppl 1:S185-90. doi: 10.1016/s1076-6332(03)80433-6.
5
Clinical applications of ultrasound contrast agents.超声造影剂的临床应用。
Ultrasonics. 1998 Feb;36(1-5):695-701. doi: 10.1016/s0041-624x(97)00123-6.
6
Contrast-enhanced magnetic resonance imaging of the liver.
J Belge Radiol. 1997 Dec;80(6):322.
7
Focal nodular hyperplasia of the liver: usefulness of superparamagnetic iron oxide-enhanced magnetic resonance imaging.肝脏局灶性结节性增生：超顺磁性氧化铁增强磁共振成像的应用价值
J Pediatr Surg. 2005 Mar;40(3):E21-5. doi: 10.1016/j.jpedsurg.2004.11.012.
8
The antileprosy agent B.663 (Clofazimine) and the reticuloendothelial system.
Int J Lepr Other Mycobact Dis. 1971 Apr-Jun;39(2):479-92.
9
Iodinated polystyrene dispersions for reticuloendothelial system studies.
J Pharm Sci. 1961 Aug;50:706-7. doi: 10.1002/jps.2600500820.
10
[Histochemical study of the experimental deposit of iron in the reticuloendothelial system].
Rev Soc Argent Biol. 1957 Jun-Aug;33(3-5):157-64.
引用本文的文献
1
Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma.确定用于胶质母细胞瘤治疗中聚焦超声增强药物递送的新疗法。
Front Oncol. 2025 Mar 13;15:1507940. doi: 10.3389/fonc.2025.1507940. eCollection 2025.
2
Unraveling distinctions between contrast-enhanced ultrasound and CT/MRI for liver mass diagnosis.解析超声造影与CT/MRI在肝脏肿块诊断中的差异
Ultrasonography. 2025 Jan;44(1):19-30. doi: 10.14366/usg.24163. Epub 2024 Oct 16.
3
Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma.超声造影剂声诺维与声诺美增强超声在诊断肝细胞癌中的个体内比较。
Abdom Radiol (NY). 2024 May;49(5):1432-1443. doi: 10.1007/s00261-024-04250-7. Epub 2024 Apr 7.
4
Dynamic contrast-enhanced ultrasonography with sonazoid predicts microvascular invasion in early-stage hepatocellular carcinoma.声诺维超声造影动态增强预测早期肝细胞癌微血管侵犯。
Br J Radiol. 2023 Nov;96(1151):20230164. doi: 10.1259/bjr.20230164. Epub 2023 Oct 3.
5
Sonazoid™ versus SonoVue for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study.声诺维对比声振造影用于高危人群诊断肝细胞癌的前瞻性、单中心、个体内、非劣效性研究。
Korean J Radiol. 2022 Nov;23(11):1067-1077. doi: 10.3348/kjr.2022.0388. Epub 2022 Sep 30.
Zotero 插件